<PAGE>
_______________________________________________________________________________
FORM 10-Q/A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________
(Mark One)
[X] AMENDMENT NO. 1 to QUARTERLY REPORT UNDER SECTION 13 OR
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 1994
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File No. 1-6639
CHARTER MEDICAL CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware 58-1076937
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
3414 Peachtree Rd., NE, Suite 1400
Atlanta, Georgia 30326
(Address of principal executive offices)
(Zip Code)
(404) 841-9200
(Registrant's telephone number, including area code)
See Table of Additional Registrants below.
___________
Not Applicable
(Former name, former address and former fiscal year,
if changed since last report)
___________
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. Yes X No
Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan
confirmed by a court. Yes X No
The number of shares of the Registrant's Common Stock outstanding as of
January 31, 1995, was 28,341,246.
_______________________________________________________________________________
<PAGE>
<PAGE>
FORM 10-Q/A
CHARTER MEDICAL CORPORATION AND SUBSIDIARIES
PART II - OTHER INFORMATION
The Registrant hereby amends the Quarterly Report on Form 10-Q for the
quarter ended December 31, 1994 by adding to Item 6(a) a Financial Data
Schedule as Exhibit 27.
Item 6. - Exhibits and Reports on Form 8-K
(a) Exhibits
4(a) Amendment No. 3, dated as of December 12, 1994, to Second
Amended and Restated Credit Agreement, dated as of May 2,
1994, among the Company, the financial institutions listed
therein, Bankers Trust Company, as Agent, and First Union
National Bank of North Carolina, as Co-Agent.
4(b) Amendment No. 4, dated as of January 11, 1995, to Second
Amended and Restated Credit Agreement, dated as of May 2,
1994, among the Company, the financial institutions listed
therein, Bankers Trust Company, as Agent, and First Union
National Bank of North Carolina, as Co-Agent.
4(c) Indenture Supplement No. 1, dated June 3, 1994, among the
Company, the Guarantors listed therein and Marine Midland
Bank, as Trustee, relating to the 11.25% Senior Subordinated
Notes due April 15, 2004, together with a schedule identifying
substantially similar documents, pursuant to Instruction 2 to
Item 601 of Regulation S-K.
27 Financial Data Schedule.
(b) Report on Form 8-K
On December 15, 1994, the Company filed a Form 8-K dated November 30,
1994 disclosing the acquisition of substantially all the assets of 10
behavioral healthcare facilities from National Medical Enterprises,
Inc.
<PAGE>
<PAGE>
FORM 10-Q/A
CHARTER MEDICAL CORPORATION AND SUBSIDIARIES
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Amendment No. 1 to the Quarterly Report on
Form 10-Q for the quarter ended December 31, 1994 to be signed on its behalf
by the undersigned thereunto duly authorized.
CHARTER MEDICAL CORPORATION
(Registrant)
Date: March 14, 1995 /s/ Lawrence W. Drinkard
Lawrence W. Drinkard
Executive Vice President - Finance
(Chief Financial Officer)
Date: March 14, 1995 /s/ John R. Day
John R. Day
Vice President and Controller
(Principal Accounting Officer)
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> SEP-30-1995
<PERIOD-END> DEC-31-1994
<CASH> 86,036,000
<SECURITIES> 0
<RECEIVABLES> 188,952,000
<ALLOWANCES> 0
<INVENTORY> 6,841,000
<CURRENT-ASSETS> 313,520,000
<PP&E> 581,821,000
<DEPRECIATION> 64,959,000
<TOTAL-ASSETS> 980,951,000
<CURRENT-LIABILITIES> 204,302,000
<BONDS> 561,014,000
<COMMON> 6,731,000
0
0
<OTHER-SE> 59,735,000
<TOTAL-LIABILITY-AND-EQUITY> 980,951,000
<SALES> 263,841,000
<TOTAL-REVENUES> 263,841,000
<CGS> 0
<TOTAL-COSTS> 220,859,000
<OTHER-EXPENSES> 23,336,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 13,864,000
<INCOME-PRETAX> 5,782,000
<INCOME-TAX> 5,433,000
<INCOME-CONTINUING> 349,000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 349,000
<EPS-PRIMARY> .01
<EPS-DILUTED> 0
</TABLE>
